GVR Report cover Pharmacy Market Size, Share & Trends Report

Pharmacy Market Size, Share & Trends Analysis Report By Product Type (Prescription, OTC), By Pharmacy Type (Retail, ePharmacy), By Region (North America, APAC), And Segment Forecasts, 2022 - 2028

  • Report ID: GVR-4-68039-701-1
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2020
  • Industry: Healthcare

Report Overview

The global pharmacy market size was valued at USD 1,008.5 billion in 2020 and is projected to expand at a compound annual growth rate (CAGR) of 4.3% from 2021 to 2028. The increasing number of people suffering from diseases, increasing aging population, and growing number of prescriptions are the key parameter driving the market. According to the National Health Services, the cost of prescriptions in the financial year 2020 - 21 increased by 3.46% as compared to 2019-20 in England. According to the Centers for Disease Control and Prevention, 45.7% of the population in the U.S. consumed at least one prescription drug between 2015 and 2018, while 21.3% of the population consumed three or more prescription drugs during the same period.

U.S. pharmacy market size, by product type, 2018 - 2028 (USD Billion)

Rapid expansion and upgradation of existing pharmacies to increase market penetration are positively impacting the market growth. For instance, in 2020, Rite Aid Corp. opened two new stores, relocated five stores, and completed store remodeling to get 1,826 remodeled stores in the fiscal year 2020. Retail and hospital pharmacies are rapidly adopting various automation devices to increase patient safety and provide rapid & accurate services to their patients. Automation systems are widely used in e-prescribing, point-of-sale programs, bar code verification, robotic dispensing, automated pill counting, interactive voice response systems, and automated prescription pick-up.

According to a survey conducted by Pharmacy Purchasing and Products on pharmacy automation devices in 2019, 84.0% of the hospital pharmacies have adopted or planned to adopt automated dispensing cabinets. Moreover, pharmacies are adopting various digitalization programs to cater to the growing consumer demand and form a profitable business model. For instance, CVS Health introduced a Digital Transformation program to personalize the healthcare experience using artificial intelligence, machine learning, data, and analytics. Moreover, in December 2021, the company announced a partnership with Microsoft to scale up retail personalization and loyalty programs using advanced machine learning by using Azure.

Such digitalization and automation strategies are estimated to drive the market during the forecast period. Pharmacies are providing various patient care services and introducing various initiatives to promote medication sales. According to an article published in National Community Pharmacy Association (NCPA) Digest in 2019, 77% of the pharmacies offered medication therapy management, 76% offered immunizations for flu, 69% offered immunization for non-flu conditions, 57% offered blood pressure monitoring, and 56% provided compounding services.

Moreover, collaborative drug therapy agreements were offered by 39% of pharmacies, diabetes training by 33%, ostomy supplies by 32%, smoking cessation by 23%, patient education classes by 16%, asthma management by 13%, and weight management by 11%. Moreover, the pharmacies also started offering COVID-19 testing and vaccination services. CVS Health acquired eight million new customers through COVID-19 testing in 2020. Pharmacies are adopting innovative strategies for different functions, such as fulfilling prescriptions. For instance, Walgreens Boots Alliance introduced micro-fulfillment centers for supporting prescription shipping demand.

 

COVID-19 Global Pharmacy market impact: 6.4% growth in revenue growth

Pandemic Impact

Post COVID Outlook

The global market increased by 6.4% from 2019 to 2020

In 2021, the market will witness an increase by 5.4% from 2020 owing to rising initiatives for automation and digitalization

The ePharmacy segment gained rapid traction during the pandemic due to the increasing number of initiatives supporting ePharmacy. Moreover, increased caseloads along with regional lockdowns augmented the demand for online pharmacies

The COVID-19 pandemic increased the adoption of online pharmacies. Post-pandemic, consumers will continue adopting ePharmacies owing to benefits, such as affordability, accessibility, and convenience

Key pharmacies were focused on providing testing kits, vaccination, and medications for COVID-19 during the pandemic

Increasing strategic initiatives undertaken by key stakeholders in the global industry along with the rising aging population and disease burden is estimated to drive market growth

 

The company plans to introduce twenty-two micro-fulfillment centers in the U.S. by the end of 2020. Moreover, key stakeholders are also adopting strategies, such as acquisitions, partnerships, and collaborations, for expanding its distribution channel and market share.  For instance, in June 2021, Medly Pharmacy, a digital pharmacy, announced its plans to acquire Pharmaca, a pharmacy chain to expand its presence in thirty different markets. In May 2021, PharmEasy, an online pharmacy, acquired Medlife, an ePharmacy, to gain a higher market share and expand its presence in the industry. With this acquisition, PharmEasy holds 60% to 70% of the ePharmacy market in India.

Product Type Insights

The prescription product type segment accounted for the largest revenue share of 82.6% in 2021. The increasing burden of chronic diseases and the growing aging population is driving the demand for prescription medications. According to the International Diabetes Association, 463 million adults were suffering from diabetes in 2019. The number of adults suffering from diabetes is estimated to increase to seven hundred million by 2045. According to the American Heart Association, 126.9 million Americans were suffering from cardiovascular disease between 2015 and 2018. Moreover, the global aging population is also increasing rapidly.

According to the United Nations, there were more than 703 million adults above 65 years of age, globally. This is estimated to increase to 1.5 billion by 2050. Increasing demand for prescription drugs for therapies, such as diabetes, cardiovascular disease, respiratory diseases, antibiotics, blood disorders, and oncology, is driving the growth of the prescription segment. The OTC segment is estimated to witness the fastest CAGR during the forecast period. An increase in demand for OTC medications for diseases, such as upper respiratory medications, oral analgesics, and heartburn medications, is driving the segment growth.

Increasing instances of cough, cold & flu are supporting the segment growth. Moreover, increasing demand for private-label OTC products, increasing availability of OTC products through online channels, growing cost of prescriptions, increasing trend of self-medication, and conversion of prescription medications to OTC medications is bolstering the segment growth. For example, in February 2020, the U.S. FDA converted prescription medications Voltaren Arthritis Pain, a diclofenac sodium topical gel; Pataday Twice Daily Relief by Alcon and Once Daily Relief by Alcon for OTC.

Pharmacy Type Insights

The retail pharmacy segment held the highest revenue share of 56.2% in 2021. The growing number of independent pharmacies and chains along with the availability of medications in supermarkets & mass retailers in countries, such as the U.S. and U.K., is driving the retail pharmacy segment. The presence of large chains, such as CVS Health, Boots Walgreens, Shoppers Drug Mart, Lloyd, and Well pharmacy, in a few countries, such as the U.S., Canada, the U.K., Australia, and Russia, is supporting the segment growth. Moreover, the rapid adoption of automation technologies, such as pharmacy robots, dispensing, and packaging systems, is driving the segment growth.

Apart from dispensing a prescription, retail pharmacies are also offering vaccination services, health management services, and thereby fueling the market growth. For instance, CVS Health offers various health management programs, such as a diabetes program for its 1.4 million customers, Chronic Kidney Disease(CKD) care management to more than 7.5 million eligible members, and an oncology care program to more than 125 provider systems in 2020. ePharmacy is estimated to be the fastest-growing segment during the forecast period. Retail sales increased rapidly during the COVID-19 pandemic.

Global pharmacy market share, by pharmacy type, 2021 (%)

Many ePharmacies witnessed an increase in revenue growth in 2020 during the pandemic. For instance, online sales of Boots U.K. increased by 105% during the lockdown. CVS Health reported a 50% increase in digital refills in the specialty product category through apps. E-pharmacies have benefits, such as privacy & confidentiality, free shipping, discounts, reduction in purchase time, and a wide range of offers. Moreover, the high adoption of digital technologies by the healthcare industry, increasing penetration of smartphones, and agrowing number of retailers introducing online channels are estimated to drive the segment growth.

Regional Insights

In 2021, North America accounted for the highest revenue share of 52.2%. It is attributed to the presence of large-scale multinational chains, such as CVS Health, Boots Walgreens, Cigna, UnitedHealth Group, Walmart, Kroger, and Rite Aid Corp. These players are adopting various initiatives and automation technologies to increase market share. For instance, Rite Aid Corp. introduced its Wellness + rewards program, which offers significant discounts and rewards to its customers. Moreover, the rapidly growing aging population is supporting market growth.

According to the report published by the U.S. Census Bureau in June 2020, the geriatric population (aged above 65 years) increased by 34.2% from 2010 to 2019. Moreover, the rapidly growing demand for OTC and prescription drugs is driving market growth potential. However, Asia Pacific is anticipated to be the fastest-growing regional market during the forecast period. Rapid growth in the pharmaceutical industry in China, and India along with growing demand for generic medications is driving pharmacies demand in the region.

Moreover, rapid expansion plans undertaken by key pharmacies are supporting market growth. For instance, in March 2021, Generic Aadhar, a pharmacy retail chain in India, launched an app to get generic medications and sell them in its outlet. In March 2020, Chemist Warehouse, Australian Pharmacy, opened its new store in Christchurch, Australia. Growing disease burden and increasing healthcare spending are also supporting the market growth. Moreover, the increasing geriatric population in Asian countries, such as Japan, is further augmenting the market growth.

Key Companies & Market Share Insights

Players operating in the market are adopting various strategies such as partnerships, collaborations, merger & acquisition, and product development to expand product portfolio and geographic presence. For instance, In January 2021, AmerisourceBergen and Walgreens Boots Alliance entered into a strategic alliance. Walgreens Boots Alliance Healthcare Business was acquired by AmerisourceBergen, enabling it to increase its focus on growing retail pharmacy business. Through this strategic partnership, the two companies are extending and expanding their commercial agreements. Some of the key players operating in the global pharmacy market are:

  • CVS Health

  • Boots Walgreens

  • Cigna

  • Walmart

  • Kroger

  • Rite Aid Corp.

  • Lloyd Pharmacy

  • Well Pharmacy

  • Humana Pharmacy Solutions

  • Matsumoto Kiyoshi

Pharmacy Market Report Scope

Report Attribute

Details

Market size value in 2022

USD 1061.4 billion

Revenue forecast in 2028

USD 1,422.1 billion

Growth rate

CAGR of 4.3% from 2021 to 2028

Base year for estimation

2021

Historical data

2016 - 2020

Forecast period

2022 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product type, pharmacy type, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Spain; Italy; Russia; Japan; China; Australia; India; Brazil; Mexico; Argentina; South Africa; UAE; Saudi Arabia

Key companies profiled

CVS Health; Boots Walgreens; Cigna; Walmart; Kroger; Rite Aid Corp.; Lloyd Pharmacy; Well Pharmacy; Humana Pharmacy Solutions; Matsumoto Kiyoshi

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global pharmacy market report on the basis of product type, pharmacy type, and region:

  • Product Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Prescription

    • OTC

  • Pharmacy Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Hospital Pharmacy

    • Retail Pharmacy

      • Chain

      • Independent

      • Others

    • ePharmacy

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

    • Latin America

      • Mexico

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.